Charles River Laboratories International Inc
NYSE:CRL
Charles River Laboratories International Inc
Total Current Liabilities
Charles River Laboratories International Inc
Total Current Liabilities Peer Comparison
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Charles River Laboratories International Inc
NYSE:CRL
|
Total Current Liabilities
$954.8m
|
CAGR 3-Years
6%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Total Current Liabilities
$13.9B
|
CAGR 3-Years
26%
|
CAGR 5-Years
19%
|
CAGR 10-Years
10%
|
|
Danaher Corp
NYSE:DHR
|
Total Current Liabilities
$7.8B
|
CAGR 3-Years
4%
|
CAGR 5-Years
11%
|
CAGR 10-Years
6%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Total Current Liabilities
$1.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
8%
|
|
Agilent Technologies Inc
NYSE:A
|
Total Current Liabilities
$2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
12%
|
CAGR 10-Years
1%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Total Current Liabilities
$6.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
17%
|
See Also
What is Charles River Laboratories International Inc's Total Current Liabilities?
Total Current Liabilities
954.8m
USD
Based on the financial report for Mar 30, 2024, Charles River Laboratories International Inc's Total Current Liabilities amounts to 954.8m USD.
What is Charles River Laboratories International Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
15%
Over the last year, the Total Current Liabilities growth was -3%. The average annual Total Current Liabilities growth rates for Charles River Laboratories International Inc have been 6% over the past three years , 13% over the past five years , and 15% over the past ten years .